- This event has passed.
deutraMed to Attend DCAT Week July 12-16
July 12, 2021 @ 8:00 am - July 16, 2021 @ 5:00 pm
deutraMed Inc. is excited to attend DCAT Week, the premier annual event for companies engaged in the Bio/Pharmaceutical manufacturing value chain. The event, hosted virtually this year by the Drug, Chemical & Associated Technologies Association, runs from July 12 to 16. DCAT Week brings together customers and suppliers from around the globe, and features education sessions, networking events and other interactive opportunities.
DCAT is the premier association for the Global Bio/Pharmaceutical Manufacturing Value Chain. The organization provides learning experiences and industry activities that enhance knowledge and create opportunities for members to expand their network of customers and suppliers.
deutraMed will be represented at DCAT Week 2021 by Lisa Stuart, the company’s Managing Director, and Darren MacVicar, Director of Sales. They invite opportunities to discuss deutraMed’s value-added deuterium-containing ingredients with representatives of the global Bio/Pharmaceutical industry. Of particular note this year is the introduction of BioPure™, a bioburden-reduced, biologically inert formulation of deuterium oxide. Produced in a Class 5 manufacturing environment, BioPure™ offers exceptional chemical and microbiological purity for demanding life science, pharmaceutical, diagnostic and biomedical applications. The company also offers CRO, CMO and CDMO services for high-value deuterium products, with support from a world-class Scientific Advisory Board.
For more information, to discuss how we can meet your D2O requirements, or to arrange a meeting at DCAT Week, please contact us at sales@deutramed.com or 1 (833) 338-8726.
About deutraMed Inc.
deutraMed™ is a breakthrough deuterium science and innovation company. We meet the growing demand for value-added deuterium-containing ingredients used mainly in the Life Sciences and High Technology sectors. We also provide research and services for next-generation deuterium products in partnership with our clients, and conduct IP-driven R&D for biopharma and bio-materials applications with support from a world-class Scientific Advisory Board.